Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration
Ying Jiang(Beijing Hospital), Ralph A. Nixon(Nathan Kline Institute for Psychiatric Research), John Alam(Hispanics in Philanthropy), Philip Scheltens(Amsterdam Neuroscience), Afina W. Lemstra(Amsterdam UMC Location VUmc), John F. Smiley(Nathan Kline Institute for Psychiatric Research), Niels D. Prins, Stephen N. Gomperts(Harvard University), Shivakumar Subbanna(Nathan Kline Institute for Psychiatric Research), Sandipkumar Darji(Nathan Kline Institute for Psychiatric Research), Philip Stavrides(Nathan Kline Institute for Psychiatric Research), John Harrison(Amsterdam Neuroscience), Sandeep Malampati(Nathan Kline Institute for Psychiatric Research), Cynthia Bleiwas(Nathan Kline Institute for Psychiatric Research), Monika Pawlik(Nathan Kline Institute for Psychiatric Research), Paul Maruff(Florey Institute of Neuroscience and Mental Health), Amanda Gardner, Charlotte E. Teunissen(Amsterdam UMC Location Vrije Universiteit Amsterdam), James Peddy(Nathan Kline Institute for Psychiatric Research), Ursula A. Germann, Balapal S. Basavarajappa(Nathan Kline Institute for Psychiatric Research), Anna Pensalfini(Nathan Kline Institute for Psychiatric Research), Dun‐Sheng Yang(Nathan Kline Institute for Psychiatric Research), Hui‐May Chu, Kelly Blackburn
Cited by 58
Related Papers
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
Autophagy Induction and Autophagosome Clearance in Neurons: Relationship to Autophagic Pathology in Alzheimer's Disease
|Journal of Neuroscience|2008|1.1k
Endocytic Pathway Abnormalities Precede Amyloid β Deposition in Sporadic Alzheimer’s Disease and Down Syndrome
|American Journal Of Pathology|2000|847